We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 1 of 1
Most popular |Most recent


Insights conversations: life sciences

USA - January 27 2015 A healthy market for M&A activity, particularly cross-border deals, and a strict regulatory environment are the big factors influencing the health...

Graham Robinson, John T. Bentivoglio, Jennifer L. Bragg.